NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia–(Newsfile Corp. – August 7, 2025) – Tincorp Metals Inc. (TSXV: TIN) (“Tincorp” or the “Company”) today announced that the Company intends to undertake a non-brokered private placement financing (the “Offering”) to raise gross …
Read More »RVN Launches Customer Portal for On-Demand Booking of Refrigerated Expedite Freight
Knoxville, Tennessee–(Newsfile Corp. – August 7, 2025) – Reefer Van Network (RVN), the leading expedite partner for the cold chain, has launched its new Customer Portal, giving shippers instant, self-serve access to book dry and temperature-controlled cargo vans and small trucks—on demand, 24/7. Reefer Van Network To view an enhanced …
Read More »Japan Gold Announces US$1 Million Private Placement
Vancouver, British Columbia–(Newsfile Corp. – August 7, 2025) – Japan Gold Corp. (TSXV: JG) (OTCQB: JGLDF) (“Japan Gold” or the “Company“) is pleased to announce a non-brokered private placement financing of 17,182,500 common shares of the Company (the “Shares“) at a price of C$0.08 per Share for gross proceeds of …
Read More »Carnegie Council Unveils New Ethics-Based Tool to Accelerate the Implementation of Climate Action in Cities
New York, New York–(Newsfile Corp. – August 7, 2025) – Carnegie Council for Ethics in International Affairs has released a new free-to-access tool for professionals working to address or limit climate change impacts in cities. Drawing upon insights from a global community of ethicists, city government actors, and nonprofits, the …
Read More »Brookmount Explorations Inc. Discusses Revenue Growth and Diversification with The MarketGems Podcast
Towson, Maryland–(Newsfile Corp. – August 7, 2025) – The MarketGems Podcast welcomed Brookmount Explorations Inc. (OTCID: BMXI) (“the Company”), a US based gold exploration and production company. CEO and Executive Director of the Company, Nils Ollquist, joined MarketGems host Matthew Dunehoo. Interview Highlights: -Brookmount Explorations Inc. has reported consistent revenue …
Read More »ALB Vodka Joins Southern Glazer’s Wine & Spirits in Nevada
Distribution Agreement Highlights Continued Brand Growth Amid Downturn in Broader Alcohol Market New York, New York–(Newsfile Corp. – August 7, 2025) – ALB® Vodka today announced a distribution agreement with Southern Glazer’s Wine & Spirits, the world’s preeminent distributor of beverage alcohol, in the state of Nevada. The agreement represents …
Read More »Equinox Gold Announces Agreement to Divest Non-Core Nevada Assets for US$115 Million
Vancouver, British Columbia–(Newsfile Corp. – August 7, 2025) – Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce the sale of its 100% interest in the Pan Mine, Gold Rock Project, and Illipah Project located in Nevada, USA (the “Nevada Assets”) to …
Read More »Happy Life Academy Founder Stoyana Natseva Honored with “Writer of the Decade” and “Woman of the Decade” Awards by the 31st Fashion, Show & Business Awards
Sofia, Bulgaria–(Newsfile Corp. – August 7, 2025) – Stoyana Natseva, founder of Happy Life Academy, was honored with the “Writer of the Decade” and “Woman of the Decade” awards by the 31st Fashion, Show & Business Awards in Sofia, Bulgaria. The prestigious recognition celebrates her transformative contributions in human development, …
Read More »Luxus Capital, Llc, the Registered Trademark Owner of Korriphila(R), Announces, Korth Germany to Produce First Limited Edition Korriphila(R) Pistol
Korriphila Redux: cc Commissions Korth Germanyto Create a Limited Edition Version of the Legendary Precision PistolLuxus Capital, LLC, the registered trademark owner of Korriphila®, announces that: Korth Germany is prepared to produce an exclusive limited edition based on Korriphila’s original designs and drawings. Bradenton, Florida–(Newsfile Corp. – August 7, 2025) …
Read More »OS Therapies Announces Statistically Significant Positive Interim 2-Year Overall Survival Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
66.6% of OST-HER2 treated patients achieved 2-year overall survival compared with 40% in the historical control group (p = 0.0046) FDA issues Biologics Licensing Application (BLA) number for OST-HER2 in preparation for anticipated BLA filing for the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma following August 27, …
Read More »
Matribhumi Samachar English